The study, performed at the University of Virginia in Charlottesville, Va., consisted of a group of 320 women with 375 palpable masses with benign features for which short-term follow-up was recommended. "We found that only one case of cancer was diagnosed for which short-term follow-up had been recommended," said Jennifer A. Harvey, M.D., lead author of the study.
"Our study of palpable breast lesions with benign features showed an acceptably low prevalence of breast cancer ─ so low that short-term follow-up is a reasonable alternative to biopsy," said Harvey.
"Application of the results of our study may reduce the number of biopsies that result in benign findings. There is also significant cost savings associated with using short-term follow-up rather than immediate biopsy," she said.